Khati, M2014-01-172014-01-172013-08Khati, M. 2013. Diagnosis of active TB using aptamers. In: 2nd International Conference and Exhibition on Pathology, Embassy Suites Las Vegas, USA, 5-7 August 2013http://hdl.handle.net/10204/71542nd International Conference and Exhibition on Pathology, Embassy Suites Las Vegas, USA, 5-7 August 2013. Abstract only attached.A lack of simple, rapid, accurate, and affordable point-of-care diagnostic tools tailored to detect active TB early enough for opportune intervention in high HIV and TB prevalence developing countries is one of defining public health problems of our generation. Therefore, to help address this problem of unmet TB diagnostic needs in developing countries; we isolated sensitive and specific classes of novel artificial nucleic acid molecules called aptamers against the 10-kDa culture filtrate protein (CFP-10) and the 6-kDa early secreted antigen target (ESAT-6), which are potent T-cell antigens that are recognised by over 70% of TB patients. We then used these aptamers to develop a TB diagnostic tool that can be used at point-of-care for early and rapid detection of the disease. We have shown in a proof-of-concept case-controlled study that the aptamer-based diagnostic tool was able to accurately detect all cases of active TB from sputum samples of patients, including smear-negative culture positive and samples from patients co-infected with HIV.enPathologyTuberculosisTBAptamersConference PresentationKhati, M. (2013). Diagnosis of active TB using aptamers. OMICS Group conferences. http://hdl.handle.net/10204/7154Khati, M. "Diagnosis of active TB using aptamers." (2013): http://hdl.handle.net/10204/7154Khati M, Diagnosis of active TB using aptamers; OMICS Group conferences; 2013. http://hdl.handle.net/10204/7154 .TY - Conference Presentation AU - Khati, M AB - A lack of simple, rapid, accurate, and affordable point-of-care diagnostic tools tailored to detect active TB early enough for opportune intervention in high HIV and TB prevalence developing countries is one of defining public health problems of our generation. Therefore, to help address this problem of unmet TB diagnostic needs in developing countries; we isolated sensitive and specific classes of novel artificial nucleic acid molecules called aptamers against the 10-kDa culture filtrate protein (CFP-10) and the 6-kDa early secreted antigen target (ESAT-6), which are potent T-cell antigens that are recognised by over 70% of TB patients. We then used these aptamers to develop a TB diagnostic tool that can be used at point-of-care for early and rapid detection of the disease. We have shown in a proof-of-concept case-controlled study that the aptamer-based diagnostic tool was able to accurately detect all cases of active TB from sputum samples of patients, including smear-negative culture positive and samples from patients co-infected with HIV. DA - 2013-08 DB - ResearchSpace DP - CSIR KW - Pathology KW - Tuberculosis KW - TB KW - Aptamers LK - https://researchspace.csir.co.za PY - 2013 T1 - Diagnosis of active TB using aptamers TI - Diagnosis of active TB using aptamers UR - http://hdl.handle.net/10204/7154 ER -